Abstract
Chronic kidney disease is a public health problem that has generated renewed interest due to poor patient outcomes and high cost. The Advancing American Kidney Health initiative aimed to transform kidney care with goals of decreasing the incidence of kidney failure and increasing the number of patients receiving home dialysis or a kidney transplant. New value-based models of kidney care that specify inclusion of pharmacists as part of the kidney care team were developed to help achieve these goals. To support this Advancing American Kidney Health-catalyzed opportunity for pharmacist engagement, the pharmacy workforce must have a fundamental knowledge of the core principles needed to provide comprehensive medication management to address chronic kidney disease and the common comorbid conditions and secondary complications. The Advancing Kidney Health through Optimal Medication Management initiative was created by nephrology pharmacists with the vision that every person with kidney disease receives optimal medication management through team-based care that includes a pharmacist to ensure medications are safe, effective, and convenient. Here, we propose education standards for pharmacists providing care for individuals with kidney disease in the outpatient setting to complement proposed practice standards.
| Original language | English (US) |
|---|---|
| Article number | 100508 |
| Journal | Kidney Medicine |
| Volume | 4 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 2022 |
Bibliographical note
Funding Information:Joanna Q. Hudson, PharmD, Rebecca Maxson, PharmD, Erin F. Barreto, PharmD, Katherine Cho, PharmD, Amanda J. Condon, PharmD, Elizabeth Goswami, PharmD, Jean Moon, PharmD, Bruce A. Mueller, PharmD, Thomas D. Nolin, PharmD, PhD, Heather Nyman, PharmD, A. Mary Vilay, PharmD, and Calvin J. Meaney, PharmD, None. Dr Hudson is a consultant for Wolters-Kluwer; Dr Maxon is a consultant for Vifor Pharma and Wolters-Kluwer; Dr Moon is a consultant for Vifor Pharma; Dr Mueller is a consultant for Wolters-Kluwer; Dr Nyman is a consultant for FAST Biomedical and Wolters-Kluwer; Dr Vilay has received consultant fees from MediBeacon and CytoSorbents, and honoraria/royalties from McGraw-Hill Education; Dr Meaney is a consultant for Wolters-Kluwer. The remaining authors declare that they have no relevant financial interests. These education standards were developed in conjunction with the nephrology pharmacy practice standards under the national Advancing Kidney Health through Optimal Medication Management (AKHOMM) initiativewww.kidneymedicationmanagement.org. The authors would like to thank Dr Wendy St. Peter (co-leader of the AKHOMM initiative) for her support, direction, and review of this manuscript. We also acknowledge the following individuals for their review of the education standards and input: Tracy Anderson-Haag, Amy Barton, Estella Davis, Ila Harris, Harold Manley, Nancy Mason, Hanlin Li, Linda Moore, Emily McCoy, and Pamela Stamm. Received December 31, 2021. Evaluated by 4 external peer reviewers, with direct editorial input from an Associate Editor who served as Acting Editor-in-Chief. Accepted in revised form May 11, 2022. The involvement of an Acting Editor-in-Chief was to comply with Kidney Medicine's procedures for potential conflicts of interest for editors, described in the Information for Authors & Journal Policies.
Publisher Copyright:
© 2022 The Authors
Keywords
- Chronic kidney disease
- comprehensive medication management
- education standards
- nephrology
- pharmacist
- practice standards
